Exploratory Clinical Trial of DQ1001 in Relapsed or Refractory Multiple Myeloma (RRMM)

Clinical trial NCT07622862 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07622862
Sponsor: Zhongshan Hospital (Xiamen), Fudan University
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Multiple Myeloma Refractory Multiple Myeloma Progression

Start date: 2026-06-01
Primary completion: 2027-09-01
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.